Technology | Oncology Information Management Systems (OIMS) | July 13, 2018

Version 2A features new task- and rule-based scheduling for all clinic resources, clinical document and form management connected to task management

RaySearch Releases New Version of RayCare OIS

July 13, 2018 — RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources.

RayCare is developing rapidly with clinical input from leading cancer centers worldwide. The first clinical version of RayCare was released in December 2017, and Iridium Cancer Network in Belgium started using it clinically after only two months. RayCare 2A introduces new features and a range of general system enhancements.

New features include:

  • Task-based and rule-based scheduling for all clinic resources;
  • Management of clinical documents and forms connected to task management; and
  • Additional treatment management functions.

RayCare’s advanced workflow capabilities have been further enhanced to enable customization of the individual patient's workflow, as well as automatic capture and management of billable codes from tasks performed in the workflow.

RayCare 2A also incorporates RayPACS, a managed picture archiving and communication system that makes it fast and easy to retrieve and share images. RayPACS is fully integrated with the RayCare workflow management system, enabling automated imaging workflows. All DICOM and non-DICOM objects relevant for radiation oncology can be stored, and rules for DICOM routing can be set up easily based on any DICOM tag.

For more information: www.raysearchlabs.com

Related Content

News | Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

Time August 08, 2022
arrow
News | Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
Feature | Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

Time August 02, 2022
arrow
News | Nuclear Imaging

July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...

Time July 27, 2022
arrow
News | Radiation Oncology

July 25, 2022 — RaySearch Laboratories AB announces the launch of RayStation* 12A, the latest version of the company’s ...

Time July 25, 2022
arrow
News | PET Imaging

July 20, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 20, 2022
arrow
News | Radiopharmaceuticals and Tracers

July 20, 2022 — -NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time July 20, 2022
arrow
Subscribe Now